Robuta

https://www.cochrane.org/evidence/CD008418_formoterol-versus-short-acting-beta-agonists-symptom-relief-adults-and-children-asthma
beta agonistssymptom reliefformoterolversusshort
https://pubmed.ncbi.nlm.nih.gov/10841798/
Adenosine receptor agonists have cardioprotective, cerebroprotective, and antiinflammatory properties. We report that a carbocyclic modification of the ribose...
purine nucleosidesanaloguespotentselectiveadenosine
https://pubmed.ncbi.nlm.nih.gov/39815782/?utm_source=newsletter.robinberzinmd.com&utm_medium=newsletter&utm_campaign=should-we-all-be-microdosing-glp-1s
GLP-1 RAs appear to have a positive effect upon mitochondria area, number and morphology, but effects upon other aspects of mitochondrial health remain...
the effectsreceptor agonistsglucagonlikepeptide
https://www.cochrane.org/hr/evidence/CD005533_addition-long-acting-beta2-agonists-inhaled-steroids-compared-higher-doses-inhaled-steroids-alone
inhaled steroidsadditionlongactingagonists
https://pubmed.ncbi.nlm.nih.gov/33354917/
Pharmacological options for management of obesity and type 2 diabetes mellitus (T2DM) in children are limited. We aimed to synthesize published randomized...
glpagonistsobesitytypediabetes
https://www.healthsystemtracker.org/brief/perspectives-from-employers-on-the-costs-and-issues-associated-with-covering-glp-1-agonists-for-weight-loss/
Oct 22, 2025 - While the share of largest employers covering GLP-1s for weight loss has increased, conversations with employers reveal their concerns about GLP-1 costs.
on theperspectivesemployerscostsissues
https://www.gov.uk/government/news/mhra-reminds-healthcare-professionals-to-advise-patients-of-the-side-effects-of-glp-1-agonists-and-to-report-misuse
The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding healthcare professionals to ensure patients are aware of the known side effects of...
healthcare professionalsthe sidemhraremindsadvise
https://www.drlisafortin.com/post/weight-loss-wonder-drug-or-dangerous-fad-the-truth-about-glp-1-agonists-ozempic-or-wegovy
With the remarkable ability to promote rapid weight loss while managing blood sugar levels, these groundbreaking medications have quickly become the talk of...
weight losswonder drugthe truthdangerousfad
https://www.pediatric-respiratory-journal.com/short-acting-beta-2-agonists-for-acute-wheezing/
position papershortactingbetaagonists
https://pubmed.ncbi.nlm.nih.gov/25980359/
The present study was done to explore the cholinergic systems operating in the wall of the isolated rat bladder. In a first set of experiments, bladder strips...
cholinergic agonistsactionsprolongedexposureisolated
https://www.iflscience.com/how-do-glp-1-agonists-like-ozempic-and-wegovy-work-82099
For drugs that are in such hot demand and have such large cultural and economic effects, you might expect the mechanism would be more widely understood.
how doglpagonistslikeozempic
https://www.forbes.com/health/weight-loss/glp-1-agonists/
Sep 24, 2023 - Here’s everything you need to know about GLP-1 agonists for weight loss including how they work, if they’re effective and who they might work for.
what you needweight lossglpagonists
https://www.health.com/glp-1-receptor-agonists-8624663
Glucagon-like peptide-1 (GLP-1) receptor agonists are drugs that treat type 2 diabetes, high blood sugar, and obesity by regulating insulin production.
receptor agonistsside effectsglpusestypes
https://www.cochrane.org/zh-hant/evidence/CD003572_no-randomised-trials-were-found-testing-short-acting-beta-2-agonists-people-bronchiectasis
randomisedtrialsfoundtestingshort
https://www.acc.org/Latest-in-Cardiology/Articles/2021/08/26/20/08/mon-830am-pronounce-esc-2021
gnrh antagonistspronouncecvsafetyvs
https://www.mdpi.com/1424-8247/14/10/988
Transient receptor potential ankyrin 1 (TRPA1) is a transmembrane protein channeling the influx of calcium ions.
the dynamicsprerequisitebindingmodesdetermine
https://www.everydayhealth.com/obesity/consumers-guide-to-glp-1-and-dual-gip-glp-1-agonists-for-obesity/
Oct 6, 2025 - GLP-1 and dual GIP/GLP-1 agonists can help people with obesity lose weight. Learn about how they work and how to talk to your doctor about these medications.
your guideglpdualgip
https://www.the-scientist.com/understanding-the-molecular-mechanisms-of-synthetic-cannabinoid-receptor-73470
Nov 3, 2025 - Biosensing plays a fundamental role in the latest technology that sheds light on how G protein-coupled receptors are activated by synthetic cannabinoid...
cannabinoid receptor agonistsunderstandingmolecularmechanismssynthetic
https://www.brighamhealthonamission.org/2025/06/02/the-efficacy-of-glp-1-agonists-in-treating-substance-use-disorder/
Jun 2, 2025 - Glucagon-like peptide-1 (GLP-1) agonists have potential to treat conditions besides metabolic disease, perhaps including substance use disorder (SUDs). Mary...
substance useefficacyglpagoniststreating
https://www.bath.ac.uk/publications/chronic-effects-of-g-protein-biased-mu-opioid-receptor-agonists-in-the-brain/
This project takes a co-ordinated transdisciplinary approach, using a combination of in vivo and ex vivo techniques.
mu opioid receptorg proteinchroniceffectsbiased
https://pubmed.ncbi.nlm.nih.gov/28620298/
Toll-like receptors (TLRs) are a class of pattern recognition receptors that play a bridging role in innate immunity and adaptive immunity. The activated TLRs...
toll like receptorantitumoractivityagonists
https://www.mdpi.com/2077-0383/13/21/6336
Background: The increased popularity and ubiquitous use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the treatment of diabetes, heart failure,...
scoping reviewreceptor agonistsglp
https://www.law360.com/healthcare-authority/cases/65c0fec7ff070b025f43c400/articles
Coverage of federal case GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION, case number 2:24-md-03094, from Pennsylvania...
receptor agonistsglucagonlikepeptideglp
https://pubmed.ncbi.nlm.nih.gov/41498755/
GLP-1 RA use was associated with a modest increase in NAION risk but not overall ocular adverse events. Findings underscore the need for long-term...
ischemic optic neuropathyreceptor agonistsassociationglp
https://www.mims.co.uk/glp-1-agonists-linked-increased-risk-chronic-cough/diabetes/article/1941129
GLP-1 agonists are associated with an increased risk of new chronic cough in people with type II diabetes, according to a large, multicentre, cohort study.
chronic coughglpagonistslinkedincreased
https://www.news-medical.net/condition/GLP-1-Agonists
Explore authoritative articles on GLP-1, semaglutide, peptide therapeutics, weight loss, diabetes, and emerging treatments. This hub delivers evidence-based...
news articlesglpagonistsresearch
https://pubmed.ncbi.nlm.nih.gov/6131355/
Cardiovascular and respiratory activity of mu, delta and kappa opioid agonists were investigated utilizing microinjections into the n. preopticus medialis...
delta anddifferentialcardiovasculareffectsmu
https://www.cochrane.org/hr/evidence/CD007949_addition-long-acting-beta2-agonists-inhaled-corticosteroids-chronic-asthma-children
inhaled corticosteroidsadditionlongactingagonists
https://www.cochrane.org/evidence/CD002873_short-acting-beta2-agonists-recurrent-wheeze-children-under-two-years-age
shortactingagonistsrecurrentwheeze